| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $92,188,897 ) (Continued on the next page) |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA250418 | Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia | 000 | 4 | NIH | 3/14/2023 | $224,070 |
| | 2023 | 2023 | St. Jude Children's Research Hospital, Inc. | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 6 | HRSA | 3/2/2023 | $134,596 |
| | 2023 | 2023 | St. Jude Children's Research Hospital, Inc. | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 6 | HRSA | 3/2/2023 | $616,469 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32CA236748 | Childhood Hematological Malignancies Training Program | 000 | 5 | NIH | 8/14/2023 | $270,617 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 001 | 7 | NIH | 3/16/2023 | $86,161 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA195547 | The St. Jude Lifetime Cohort | 001 | 9 | NIH | 6/21/2023 | $1,109,248 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI040646 | Non-canonical functions of autophagy proteins | 000 | 26 | NIH | 5/12/2023 | $448,750 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA260175 | XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION | 000 | 2 | NIH | 2/7/2023 | $407,999 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA270157 | Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts | 001 | 2 | NIH | 9/14/2023 | $13,286 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS123116 | Interneuron circuits in the spinal motor system | 000 | 3 | NIH | 4/26/2023 | $448,207 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121249 | Improving genetically engineered T cells for medulloblastomas | 000 | 3 | NIH | 2/23/2023 | $444,775 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY030180 | Cell-type? and developmental stage?specific regulation of gene expression in the retina | 000 | 4 | NIH | 1/31/2023 | $448,750 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM135599 | Structural and functional studies of chromatin modifiers | 001 | 4 | NIH | 3/8/2023 | $37,695 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM131891 | Understanding Phase Separation in Biology and Disease | 000 | 5 | NIH | 4/4/2023 | $538,500 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 000 | 7 | NIH | 12/16/2022 | $969,300 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 001 | 7 | NIH | 1/27/2023 | $764,284 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI105129 | Contribution of LukED to Staphylococcus aureus pathobiology | 002 | 11 | NIH | 9/19/2023 | $556,035 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | P30CA021765 | Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations | 004 | 44 | NIH | 9/15/2023 | $200,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS129795 | Structural analysis of the human LRRK2 | 000 | 1 | NIH | 5/16/2023 | $455,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K23HL166697 | School Readiness Intervention for Preschool Children with Sickle Cell Disease | 000 | 1 | NIH | 5/10/2023 | $146,665 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37CA276215 | Sustainability determinants of an intervention to identify clinical deterioration and improve childhood cancer survival in low-resource hospitals | 000 | 1 | NIH | 3/31/2023 | $682,433 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA273326 | Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia | 000 | 2 | NIH | 8/21/2023 | $416,766 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99DK135910 | Elucidating function of disease-related SAMD9L mutations in hematopoiesis | 000 | 1 | NIH | 5/18/2023 | $90,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA273455 | Cancer-based discovery of novel mechanisms of chromatin control | 000 | 1 | NIH | 4/6/2023 | $416,325 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS122859 | GENETICALLY ENGINEERED T CELLS FOR DIPG | 000 | 2 | NIH | 7/17/2023 | $503,626 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI170765 | Targeting NuoD for the treatment of H. pylori | 000 | 1 | NIH | 4/28/2023 | $865,480 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI170984 | Targeting the immunoproteasome as a novel therapeutic strategy for hemophagocytic lymphohistiocytosis | 000 | 1 | NIH | 7/5/2023 | $273,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99MH129617 | A novel circuit underlying amotivation in a mouse model of 22q11DS | 000 | 1 | NIH | 12/12/2022 | $88,374 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08DK134873 | Consequences of gain-of-function RPA1 mutations on telomere function and hematopoiesis | 000 | 2 | NIH | 8/24/2023 | $166,950 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01HL163983 | Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | 001 | 1 | NIH | 9/7/2023 | $0 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01HL163983 | Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | 000 | 1 | NIH | 8/31/2023 | $1,183,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99AI166019 | TONSILS: AN UNRECOGNIZED ROLE IN INFLUENZA VIRUS EVOLUTION | 000 | 2 | NIH | 7/12/2023 | $100,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32CA272387 | T32 Training Program in Pediatric Immuno-Oncology and Immunotherapy | 000 | 2 | NIH | 8/28/2023 | $235,013 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI173909 | Determination of chromatin protein dynamics in CD8 T cells | 000 | 1 | NIH | 6/23/2023 | $273,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA281868 | Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology | 000 | 1 | NIH | 9/7/2023 | $819,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA281823 | Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma | 000 | 1 | NIH | 9/7/2023 | $807,680 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA261713 | PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention | 001 | 2 | NIH | 9/14/2023 | $4,164 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS123081 | Genome Stability in Glia & Disease | 000 | 2 | NIH | 6/23/2023 | $455,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K01DK138265 | Elucidating the role of DCAF7 on hematopoietic stem cell maintenance | 000 | 1 | NIH | 9/12/2023 | $134,549 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA279926 | Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth? | 000 | 1 | NIH | 6/19/2023 | $263,778 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K00NS125690 | Gene regulatory mechanisms governed by the ASXL1/HCF1/OGT complex during neurogenesis | 000 | 2 | NIH | 6/30/2023 | $86,378 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA261713 | PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention | 000 | 2 | NIH | 7/20/2023 | $204,063 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI166693 | Legacy of Obesity on Influenza and Coronavirus | 000 | 2 | NIH | 10/20/2022 | $91,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI166434 | Astrovirus CNS Infections | 000 | 2 | NIH | 10/28/2022 | $91,000 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25GM150178 | Memphis STEM-M Ambassadors | 000 | 1 | NIH | 9/5/2023 | $263,200 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R03AI178552 | Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing | 000 | 1 | NIH | 6/22/2023 | $103,500 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01AI176470 | Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs | 000 | 1 | NIH | 5/24/2023 | $479,100 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HL165798 | ULK-mediated autophagy of ?-globin in ?-thalassemia | 000 | 2 | NIH | 7/14/2023 | $652,585 |
| | 2023 | 2023 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA266600 | EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA | 000 | 2 | NIH | 6/30/2023 | $677,596 |
|
